Effect of Fibrate on Lipoprotein(a) Level in Hypertriglyceridemic Patients
Sung Jin Kim, Kyung Eun Lee, Sung Ho Lee, Kap Sung Jung, Kwang Je Lee, Tae Ho Kim, Hong Sook Ko, Chee Jeong Kim, Wang Seong Ryu
Abstract
Open-access reader
Sung Jin Kim, Kyung Eun Lee, Sung Ho Lee, Kap Sung Jung, Kwang Je Lee, Tae Ho Kim, Hong Sook Ko, Chee Jeong Kim, Wang Seong Ryu
Abstract
Open-access reader
Background and Objectives:The responses of lipoprotein (a) [Lp(a)] to lipid-lowering drugs are different from those of other lipids and lipoproteins.Most reports on the effect of fibrate on the Lp (a) level have only a few cases, with inconsistent results.This study was designed to evaluate the effect of fibrate on the Lp (a) level in hypertriglyceridemic patients.Subjects and Methods:Patients with either a triglyceride (TG) level over 300 mg/dL or TG level over 200 mg/dL and a high density lipoprotein cholesterol level below 40 mg/dL, were enrolled.They were treated with either fibrate (Fibrate group, n=29) or general measures (Control group, n=29).Gender and age matched patients with hypercholeste-rolemia were adopted and treated with statin (Statin group, n=29).The lipid and lipoprotein levels were measured before and after the medication for 2 months.Results:The baseline Lp (a) levels were similar between the Fibrate and Control groups (p=0.19).Fibrate therapy increased the Lp (a) level from 10.3±16.4 to 15.1±15.2mg/dL (p=0.003),but there were no changes in the Lp (a) levels in the Statin and Control groups.Before the treatment, the Lp (a) levels were negatively associated with the TG levels (r=-0.36,p=0.001).The relationship became weaker and insignificant after the medication.The more the TG level was decreased, the more the Lp (a) level was increased in all of the cases (r=-0.35,p=0.001) as well as in the Fibrate group (r=-0.46,p=0.013).Conclusion:Fibrate increased the Lp (a) level, and this elevation was associated with the reduction in the TG level.This finding might be related with a lesser cardioprotective effect of fibrate than that of statin in addition to the effect on the cholesterol level.(Korean Circulation J 2005; 35:30-36) KEY WORDS:Fenofibric acid;Gemfibrozil;lipoprotein(a);Lipids;Lipoproteins.서 론 Lipoprotein(a)[Lp(a)]는 저밀도지단백(LDL)에 아포지 단백(a)가 disulfide 결합에 연결되어 있는 지단백이다.하지 만 다른 지단백과는 전혀 다른 대사 과정을 가지고 있어, 혈 중 농도가 주로 유전적 다형성에 의해 결정되고, 나이, 성별, 식이 및 비만도 등과 같이 일반적으로 지질 농도에 관여하 는 인자들과의 관계는 미미하다.1)2) Lp(a) 농도는 비록 매 우 약하지만 중성지방과 역상관관계가 있으며, 총콜레스테 롤 및 그 분획들과도 양의 상관관계가 있다. 3) Lp(a)는 급성 반응물질(acute phase reactant)로써 급성심근경색이나 수 술
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background and Objectives:The responses of lipoprotein (a) [Lp(a)] to lipid-lowering drugs are different from those of other lipids and lipoproteins.Most reports on the effect of fibrate on the Lp (a) level have only a few cases, with inconsistent results.This study was designed to evaluate the effect of fibrate on the Lp (a) level in hypertriglyceridemic patients.Subjects and Methods:Patients with either a triglyceride (TG) level over 300 mg/dL or TG level over 200 mg/dL and a high density lipoprotein cholesterol level below 40 mg/dL, were enrolled.They were treated with either fibrate (Fibrate group, n=29) or general measures (Control group, n=29).Gender and age matched patients with hypercholeste-rolemia were adopted and treated with statin (Statin group, n=29).The lipid and lipoprotein levels were measured before and after the medication for 2 months.Results:The baseline Lp (a) levels were similar between the Fibrate and Control groups (p=0.19).Fibrate therapy increased the Lp (a) level from 10.3±16.4 to 15.1±15.2mg/dL (p=0.003),but there were no changes in the Lp (a) levels in the Statin and Control groups.Before the treatment, the Lp (a) levels were negatively associated with the TG levels (r=-0.36,p=0.001).The relationship became weaker and insignificant after the medication.The more the TG level was decreased, the more the Lp (a) level was increased in all of the cases (r=-0.35,p=0.001) as well as in the Fibrate group (r=-0.46,p=0.013).Conclusion:Fibrate increased the Lp (a) level, and this elevation was associated with the reduction in the TG level.This finding might be related with a lesser cardioprotective effect of fibrate than that of statin in addition to the effect on the cholesterol level.(Korean Circulation J 2005; 35:30-36) KEY WORDS:Fenofibric acid;Gemfibrozil;lipoprotein(a);Lipids;Lipoproteins.서 론 Lipoprotein(a)[Lp(a)]는 저밀도지단백(LDL)에 아포지 단백(a)가 disulfide 결합에 연결되어 있는 지단백이다.하지 만 다른 지단백과는 전혀 다른 대사 과정을 가지고 있어, 혈 중 농도가 주로 유전적 다형성에 의해 결정되고, 나이, 성별, 식이 및 비만도 등과 같이 일반적으로 지질 농도에 관여하 는 인자들과의 관계는 미미하다.1)2) Lp(a) 농도는 비록 매 우 약하지만 중성지방과 역상관관계가 있으며, 총콜레스테 롤 및 그 분획들과도 양의 상관관계가 있다. 3) Lp(a)는 급성 반응물질(acute phase reactant)로써 급성심근경색이나 수 술
Key concepts: Fibrate, Medicine, Internal medicine, Triglyceride, Lipoprotein(a), Statin, Lipoprotein, Endocrinology